Taking a new biomarker into routine use--a perspective from the routine clinical biochemistry laboratory (Q34694790)

4 August 2017

4 references

19 June 2019

19 September 2019

19 November 2020

20 November 2020

Taking a new biomarker into routine use--a perspective from the routine clinical biochemistry laboratory (English)

1 reference

biomedical investigative technique

4 August 2017

1 reference

19 November 2020

1 reference

19 September 2019

laboratory diagnostics

1 reference

20 November 2020

Catharine Sturgeon

1

1 reference

4 August 2017

Robert Hill

series ordinal

2

1 reference

4 August 2017

Glen L Hortin

series ordinal

3

1 reference

4 August 2017

Douglas Thompson

series ordinal

4

1 reference

4 August 2017

publication date

22 November 2010

1 reference

Proteomics - Clinical Applications

4 August 2017

1 December 2010

4 references

19 June 2019

19 September 2019

19 November 2020

20 November 2020

5 references

4 August 2017

19 June 2019

19 September 2019

19 November 2020

20 November 2020

4

1 reference

4 August 2017

issue

12

1 reference

4 August 2017

page(s)

892-903

1 reference

Creative Commons Attribution 2.5 Generic

4 August 2017

copyright license

4 references

19 June 2019

19 September 2019

19 November 2020

Banking of clinical samples for proteomic biomarker studies: a consideration of logistical issues with a focus on pre-analytical variation

20 November 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

Assessing the impact of biomarkers on patient outcome: an obligatory step

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

International efforts to develop biospecimen best practices.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

Ten steps towards improving prognosis research.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

Sources of bias in specimens for research about molecular markers for cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

Monte Carlo simulation in establishing analytical quality requirements for clinical laboratory tests meeting clinical needs

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

The modernisation of pathology and laboratory medicine in the UK: networking into the future

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

Standardization of FSH, LH and hCG--current position and future prospects

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

Usage of troponin in the real world: a lesson for the introduction of biochemical assays

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

Inherent biological variation and reference values

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

Changing clinical behaviour by making guidelines specific

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

The architecture of diagnostic research

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

Precipitating antigens of the normal human prostate.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

When do new biomarkers make economic sense?

7 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000073

Assessing the clinical impact of prostate-specific antigen assay variability and nonequimolarity: a simulation study based on the population of the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000073

The rise and fall of C-reactive protein: managing demand within clinical biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000073

Reference reagents for prostate-specific antigen (PSA): establishment of the first international standards for free PSA and PSA (90:10)

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3060337

Qualification versus validation of biomarkers

26 October 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201000073

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

21 January 2018

1 reference

12 December 2020

Development of novel IVD assays: a manufacturer's perspective

1 reference

12 December 2020

Novel markers, a payer's perspective: commissioning a new service

1 reference

12 December 2020

Improving the clinical value of laboratory information and permitting a common global approach to diseases. Foreword

1 reference

12 December 2020

Managing demand for pathology tests: financial imperative or duty of care?

1 reference

12 December 2020

Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice?

1 reference

12 December 2020

Proteomics: a new diagnostic frontier

1 reference

12 December 2020

Identifiers

DOI

10.1002/PRCA.201000073

1 reference

4 August 2017

1 reference

4 August 2017

1 reference